Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer
To the Editor In a recent article, Melisko et al reported vaginal estradiol to cause little increase in plasma estradiol levels during treatment with aromatase inhibitors. Their data raise some concerns.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου